• Pharmacist pay by state

    The average pharmacist's salary in the U.S. is $134,790, and 15 states and Washington, D.C., are above the average, according to the most recent data from the Bureau of Labor Statistics. 
  • How does your system manage rare disease patients? Becker's wants to hear.

    Sponsored
    Fill out this short survey here and attend our annual meeting for free.
  • HHS 'misses the mark' in drug shortage proposal, ASHP says

    The American Society of Health-System Pharmacists partly welcomed HHS' 18-page policy recommendations for drug shortage strategies, but the organization said it "proposes concerning penalties."
  • Amylyx to swipe ALS from market after study failure

    Amylyx Pharmaceuticals is withdrawing its FDA-approved therapy for amyotrophic lateral sclerosis, Relyvrio, from the market after a phase 3 study failure, the company said April 4. 
  • CVS Caremark leader jabs Cost Plus Drugs; Mark Cuban responds

    David Joyner, executive vice president of CVS Health and president of CVS Caremark, called out Mark Cuban's drug company in a paid op-ed Fortune published April 3. 
  • 5 top-paying industries for pharmacists

    On average, general hospitals pay pharmacists more than retailers, but both industries are not among the five highest paying for the profession, according to data from the Bureau of Labor Statistics.
  • FDA approves antibiotic for 3 uses

    On April 3, the FDA approved Zevtera, an antibiotic with three different uses. 
  • CVS expands financial assistance for pharmacy students

    CVS Health on April 3 unveiled a new tuition assistance program for pharmacy interns and a scholarship program for students in pharmacy school. 
  • A 'crystal ball prediction' for more 340B protections: ASHP expert

    More than 25 states have enacted laws designed to protect against pharmacy benefit managers' discriminatory practices in the 340B program, the American Society of Health-System Pharmacists said April 2. 
  • HHS pitches rewards for hospitals with drug shortage solutions

    Every year, U.S. hospitals spend at least $600 million to mitigate drug shortages, according to HHS. On April 2, the department proposed financial incentives for hospitals with resilient drug supplies. 
  • 3 drugmakers announce recalls

    In the past week, three pharmaceutical companies have recalled medications because of patient safety concerns. 
  • Amazon Pharmacy expands same-day delivery

    Amazon Pharmacy is now offering same-day prescription medicine deliveries for customers in New York City and Los Angeles, with plans to expand to more than a dozen cities by the end of the year.
  • 10 drugs now in shortage

    Since March 20, 10 more drugs are either in short supply or discontinued — and the healthcare supply chain industry is watching whether the collapse of a Baltimore bridge might cause disruptions. 
  • 20 pharmacist- and dermatologist-recommended health products

    On March 28, U.S. News & World Report released its latest over-the-counter medicine and health products ranking.
  • Minnesota system adopts ScripTalk

    Essentia Health, a 14-hospital system based in Duluth, Minn., launched a free tool March 26 to verbalize prescription labels. 
  • Zepbound in shortage

    Patients, pharmacists and physicians are reporting a strained supply of Zepbound, Eli Lilly's new weight loss drug, as the drugmaker and the FDA say the medication is available, according to Bloomberg. 
  • FDA hands warning to New York hospital's drug researcher

    FDA investigators said they found "objectionable conditions" during medication research at Columbia University Medical Center Kreitchman PET Center, according to a warning letter published March 26. 
  • FDA inspections in hospitals on decline due to shortages: Report

    During a yearslong dip of the FDA inspecting clinical research in hospitals and other care sites, the U.S. Government Accountability Office said the agency should bolster its retention and recruitment efforts. 
  • Amgen sues Colorado for potential price limit on arthritis drug

    Five months before Colorado's Prescription Drug Affordability Board will vote on how much to cap the cost of Amgen's Enbrel, the drugmaker filed a lawsuit.
  • FDA approves Merck drug for rare lung disorder

    On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition. 
  • CVS workers in Las Vegas 1st to seek unionization

    About 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare filed to unionize March 25, making them the first in their industry to seek unionization. 

Featured Whitepapers

Featured Webinars

>